Orçay Ortaköy Çay Sanayi ve Ticaret Anonim Sirketi And 2 More To Consider
Uncategorized
Orçay Ortaköy Çay Sanayi ve Ticaret Anonim Sirketi And 2 More To Consider
08 mins
The Middle Eastern stock markets have recently experienced volatility, with Gulf shares slipping due to geopolitical tensions affecting investor sentiment. Despite these challenges, the appeal of penny stocks remains significant for investors looking for growth opportunities at lower price points. Penny stocks, often representing smaller or newer companies, can offer a unique blend of value and potential growth when supported by strong financials and sound fundamentals.
Top 10 Penny Stocks In The Middle East
Name
Share Price
Market Cap
Financial Health Rating
Al-Modawat Specialized Medical (SASE:9594)
SAR4.39
SAR312.54M
★★★★☆☆
Alpha Data PJSC (ADX:ALPHADATA)
AED1.48
AED1.48B
★★★★★☆
Sharjah Insurance Company P.S.C (ADX:SICO)
AED1.52
AED228M
★★★★★★
Al Wathba National Insurance Company PJSC (ADX:AWNIC)
AED3.10
AED641.7M
★★★★★★
Dubai Investments PJSC (DFM:DIC)
AED3.74
AED15.77B
★★★★★☆
Al Waha Capital PJSC (ADX:WAHA)
AED1.87
AED3.54B
★★★★★☆
Union Properties (DFM:UPP)
AED0.719
AED3.08B
★★★★★☆
Abu Dhabi National Hotels Company PJSC (ADX:ADNH)
AED0.368
AED4.65B
★★★★★★
Sharjah Cement and Industrial Development (PJSC) (ADX:SCIDC)
Let’s dive into some prime choices out of the screener.
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: Orçay Ortaköy Çay Sanayi ve Ticaret Anonim Sirketi focuses on the production, marketing, and sale of tea and related products mainly in Turkey, with a market capitalization of TRY330.40 million.
Operations: The company generates its revenue primarily from the food processing segment, amounting to TRY661.59 million.
Market Cap: TRY330.4M
Orçay Ortaköy Çay Sanayi ve Ticaret Anonim Sirketi, with a market cap of TRY330.40 million, reported sales of TRY661.59 million for 2025 but remains unprofitable, with net losses increasing to TRY161.4 million from the previous year. Despite its financial challenges, Orçay has managed to reduce its debt-to-equity ratio significantly over five years and maintains a positive cash flow allowing for a cash runway exceeding three years. However, short-term liabilities surpass short-term assets by TRY64.5 million, indicating potential liquidity concerns despite long-term liabilities being covered by current assets.
IBSE:ORCAY Financial Position Analysis as at May 2026
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Allmed Solutions Ltd develops, manufactures, and markets minimally invasive medical products across various disciplines in Israel and internationally with a market cap of ₪35.51 million.
Operations: Allmed Solutions Ltd has not reported any specific revenue segments.
Market Cap: ₪35.51M
Allmed Solutions Ltd, with a market cap of ₪35.51 million, is pre-revenue and has reported increasing net losses, reaching ILS 14.12 million for 2025. Despite the financial challenges, the company remains debt-free and has not diluted shareholders over the past year. Its short-term assets of ₪30.4 million comfortably cover both short-term liabilities (₪2.9M) and long-term liabilities (₪527K). However, its share price has been highly volatile recently, reflecting investor uncertainty in its future prospects given its unprofitable status and negative return on equity of -50.32%. The management team shows experience with an average tenure of 4.2 years.
TASE:ALMD Debt to Equity History and Analysis as at May 2026
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: Pomvom Ltd operates a cloud-based digital platform that documents visitor experiences across Israel, Japan, Europe, and the United States with a market cap of ₪19.65 million.
Operations: The company’s revenue is generated from its data processing segment, amounting to ₪220.90 million.
Market Cap: ₪19.65M
Pomvom Ltd, with a market cap of ₪19.65 million, reported annual sales of ₪220.9 million for 2025 but remains unprofitable with a net loss of ₪8.67 million. Despite this, the company has not diluted shareholders recently and holds more cash than total debt, indicating financial prudence amidst high volatility in its share price. The management team is experienced with an average tenure of 7.1 years, and the board averages 4.6 years in tenure, suggesting stability in leadership as they navigate challenges like increased debt levels and negative return on equity at -58.73%.
TASE:PMVM Revenue & Expenses Breakdown as at May 2026
Taking Advantage
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include IBSE:ORCAY TASE:ALMD and TASE:PMVM.
This article was originally published by Simply Wall St.
